Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christiane Pott

Showing results (81-90 of 114) with videos related to

Pageof 12
Sort By:
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Hemasphere|April 21, 2020
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL NetworkDaniela Drandi, Marion Alcantara, Ichrafe Benmaad, et al.
Blood|December 25, 2009
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studyChristiane Pott, Eva Hoster, Marie-Helene Delfau-Larue, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
Blood|July 28, 2011
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 casesAnastasia Hadzidimitriou, Andreas Agathangelidis, Nikos Darzentas, et al.
Hemasphere|May 4, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trialFrancesca Cordero, Simone Ferrero, Simone Pernice, et al.
International Journal of Cancer|November 18, 2018
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemiaNikos Papakonstantinou, Stavroula Ntoufa, Maria Tsagiopoulou, et al.
Blood Cancer Journal|April 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA studyClémentine Sarkozy, Loïc Chartier, Vincent Ribrag, et al.
Blood|April 14, 2011
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsItziar Salaverria, Claudia Philipp, Ilske Oschlies, et al.
Cancer Research|April 20, 2019
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaJennifer Hüllein, Mikołaj Słabicki, Maciej Rosolowski, et al.
Pageof 12

Showing results (81-90 of 114) with videos related to

Sort By:
Pageof 12
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Hemasphere|April 21, 2020
Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL NetworkDaniela Drandi, Marion Alcantara, Ichrafe Benmaad, et al.
Blood|December 25, 2009
Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup studyChristiane Pott, Eva Hoster, Marie-Helene Delfau-Larue, et al.
Genome Medicine|May 2, 2019
A modular transcriptome map of mature B cell lymphomasHenry Loeffler-Wirth, Markus Kreuz, Lydia Hopp, et al.
Blood|July 28, 2011
Is there a role for antigen selection in mantle cell lymphoma? Immunogenetic support from a series of 807 casesAnastasia Hadzidimitriou, Andreas Agathangelidis, Nikos Darzentas, et al.
Hemasphere|May 4, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trialFrancesca Cordero, Simone Ferrero, Simone Pernice, et al.
International Journal of Cancer|November 18, 2018
Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemiaNikos Papakonstantinou, Stavroula Ntoufa, Maria Tsagiopoulou, et al.
Blood Cancer Journal|April 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA studyClémentine Sarkozy, Loïc Chartier, Vincent Ribrag, et al.
Blood|April 14, 2011
Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adultsItziar Salaverria, Claudia Philipp, Ilske Oschlies, et al.
Cancer Research|April 20, 2019
MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt LymphomaJennifer Hüllein, Mikołaj Słabicki, Maciej Rosolowski, et al.
Pageof 12